These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26535926)

  • 1. Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
    Snell-Bergeon JK
    Diabetes Technol Ther; 2015 Nov; 17(11):759-62. PubMed ID: 26535926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Nov; 17(11):773-9. PubMed ID: 26167948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are patients with diabetes mellitus satisfied with technologies used to assist with diabetes management and coping?: A structured review.
    Harrison S; Stadler M; Ismail K; Amiel S; Herrmann-Werner A
    Diabetes Technol Ther; 2014 Nov; 16(11):771-83. PubMed ID: 25069057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes.
    Manning ML; Singh H; Stoner K; Habif S
    J Diabetes Sci Technol; 2020 Mar; 14(2):309-317. PubMed ID: 32028790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
    Nørgaard K; Shin J; Welsh JB; Gjessing H
    J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus.
    Schipper C; Musholt P; Niemeyer M; Qvist M; Löffler A; Forst T; Pfützner A
    Curr Med Res Opin; 2012 Aug; 28(8):1297-303. PubMed ID: 22746353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
    J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy.
    Barnard KD; Bromba M; de Lange M; Halbron M; Levy BL; Lévy M; Lippmann-Grob B; Walshe K; Ziegler R
    J Diabetes Sci Technol; 2015 Mar; 9(2):231-6. PubMed ID: 25591855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].
    Schiffers T
    Psychother Psychosom Med Psychol; 1997 Jul; 47(7):249-54. PubMed ID: 9333836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous insulin infusion systems in type 2 diabetes.
    Kesavadev J
    J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump therapy: guidelines for successful outcomes.
    Scheiner G; Sobel RJ; Smith DE; Pick AJ; Kruger D; King J; Green K
    Diabetes Educ; 2009; 35 Suppl 2():29S-41S; quiz 28S, 42S-43S. PubMed ID: 19318690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.